1. Report Introduction 2. Chronic Idiopathic Constipation (CIC) Market Overview at a Glance 2.1. Market Share Distribution of Chronic Idiopathic Constipation (CIC) in 2017 2.2. Market Share Distribution of Chronic Idiopathic Constipation (CIC) in 2028 3. Disease Background and Overview: Chronic Idiopathic Constipation (CIC) 3.1. Introduction 3.2. Symptoms 3.3. Etiology 3.4. Risk Factors 3.5. Pathophysiology 3.6. Diagnosis 3.7. Treatment 4. Epidemiology and Patient Population 4.1. Key Findings 4.2. Total Prevalent/ Incident Patient Population of Chronic Idiopathic Constipation (CIC) in 7MM 4.3. Total Prevalent Patient Population of Chronic Idiopathic Constipation (CIC) in 7MM – By Countries 5. Epidemiology of Chronic Idiopathic Constipation (CIC) by Countries 5.1. United States 5.1.1. Assumptions and Rationale 5.1.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) 5.1.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) *Indication Specific 5.1.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) *Indication Specific 5.1.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) 5.1.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC) 5.2. EU5 5.3. Assumptions and Rationale 5.4. Germany 5.4.1. Assumptions and Rationale 5.4.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) 5.4.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) * 5.4.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) * 5.4.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) 5.4.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC) 5.5. France 5.5.1. Assumptions and Rationale 5.5.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) 5.5.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) * 5.5.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) * 5.5.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) 5.5.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC) 5.6. Italy 5.6.1. Assumptions and Rationale 5.6.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) 5.6.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) * 5.6.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) * 5.6.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) 5.6.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC) 5.7. Spain 5.7.1. Assumptions and Rationale 5.7.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) 5.7.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) * 5.7.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) * 5.7.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) 5.7.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC) 5.8. United Kingdom 5.8.1. Assumptions and Rationale 5.8.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) 5.8.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) * 5.8.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) * 5.8.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) 5.8.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC) 5.9. Japan 5.9.1. Assumptions and Rationale 5.9.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) 5.9.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) * 5.9.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) * 5.9.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) 5.9.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC) 6. Current Treatment & Medical practices 6.1. Treatment Algorithm 6.2. Treatment Guidelines 7. Unmet Needs of the Chronic Idiopathic Constipation (CIC) 8. Marketed Therapies 8.1. Drug A: Company 1 8.1.1. Drug Description 8.1.2. Mechanism of Action 8.1.3. Regulatory Milestones 8.1.4. Advantages & Disadvantages 8.1.5. Product Profile 8.2. Drug B: Company 2 8.2.1. Drug Description 8.2.2. Mechanism of Action 8.2.3. Regulatory Milestones 8.2.4. Advantages & Disadvantages 8.2.5. Product Profile 9. Pipeline Therapies – At a glance 10. Key Cross Competition 11. Emerging Therapies for Chronic Idiopathic Constipation (CIC) 11.1. Drug C: Company 3 11.1.1. Drug Description 11.1.2. Clinical Trials Details 11.1.3. Safety and Efficacy Profile 11.1.4. Advantages & Disadvantages 11.1.5. Pipeline Development Activities 11.1.6. Product Profile 11.2. Drug D: Company 4 11.2.1. Drug Description 11.2.2. Clinical Trials Details 11.2.3. Safety and Efficacy Profile 11.2.4. Advantages & Disadvantages 11.2.5. Pipeline Development Activities 11.2.6. Product Profile 12. Chronic Idiopathic Constipation (CIC) : 7MM Market Analysis 12.1. 7MM Market Size of Chronic Idiopathic Constipation (CIC) 12.2. 7MM Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) 12.3. 7MM Market Sales of Chronic Idiopathic Constipation (CIC) by Products 13. Chronic Idiopathic Constipation (CIC) : Country-Wise Market Analysis 13.1. United States 13.1.1. Market Size of Chronic Idiopathic Constipation (CIC) in United States 13.1.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in United States 13.1.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in United States 13.1.4. Analysis of Upcoming Therapies and their Impact on the Market 13.2. EU-5 13.2.1. Germany 13.2.1.1. Market Size of Chronic Idiopathic Constipation (CIC) in Germany 13.2.1.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in Germany 13.2.1.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in Germany 13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market 13.2.2. France 13.2.2.1. Market Size of Chronic Idiopathic Constipation (CIC) in France 13.2.2.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in France 13.2.2.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in France 13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market 13.2.3. Italy 13.2.3.1. Market Size of Chronic Idiopathic Constipation (CIC) in Italy 13.2.3.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in Italy 13.2.3.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in Italy 13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market 13.2.4. Spain 13.2.4.1. Market Size of Chronic Idiopathic Constipation (CIC) in Spain 13.2.4.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in Spain 13.2.4.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in Spain 13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market 13.2.5. United Kingdom 13.2.5.1. Market Size of Chronic Idiopathic Constipation (CIC) in United Kingdom 13.2.5.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in United Kingdom 13.2.5.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in United Kingdom 13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market 13.3. Japan 13.3.1. Market Size of Chronic Idiopathic Constipation (CIC) in Japan 13.3.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in Japan 13.3.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in Japan 13.3.4. Analysis of Upcoming Therapies and their Impact on the Market 14. Market Drivers 15. Market Barriers 16. Appendix 17. Report Methodology 17.1. Sources 18. DelveInsight Capabilities 19. Disclaimer 20. About DelveInsight

Table 1: Total Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in 7MM Table 2: Total Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in 7MM by Countries Table 3: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Table 4: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Table 5: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Table 6: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Table 7: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Table 8: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Table 9: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Table 10: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Table 11: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Table 12: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Table 13: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Table 14: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Table 15: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Table 16: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Table 17: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Table 18: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Table 19: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Table 20: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Table 21: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Table 22: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Table 23: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Table 24: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Table 25: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Table 26: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Table 27: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Table 28: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Table 29: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Table 30: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Table 31: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Table 32: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Table 33: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Table 34: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Table 35: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Table 36: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Table 37: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Table 38: Marketed Therapies Table 39: Emerging Therapies Table 40: Key Cross Competition Table 41:7MM- Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Table 42:7MM- Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 43:7MM- Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 44: United States-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Table 45: United States-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 46: United States-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 47: Germany-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Table 48: Germany-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 49: Germany-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 50: France-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Table 51: France-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 52: France-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 53: Italy-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Table 54: Italy-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 55: Italy-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 56: Spain-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Table 57: Spain-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 58: Spain-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 59:UK-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Table 60:UK-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 61:UK-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 62: Japan-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Table 63: Japan-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Table 64: Japan-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 1: Total Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in 7MM Figure 2: Total Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in 7MM by Countries Figure 3: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Figure 4: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Figure 5: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Figure 6: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Figure 7: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028) Figure 8: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Figure 9: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Figure 10: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Figure 11: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Figure 12: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028) Figure 13: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Figure 14: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Figure 15: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Figure 16: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Figure 17: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028) Figure 18: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Figure 19: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Figure 20: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Figure 21: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Figure 22: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028) Figure 23: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Figure 24: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Figure 25: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Figure 26: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Figure 27: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028) Figure 28: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Figure 29: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Figure 30: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Figure 31: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Figure 32: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028) Figure 33: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Figure 34: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Figure 35: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Figure 36: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Figure 37: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028) Figure 38: Marketed Therapies Figure 39: Emerging Therapies Figure 40: Key Cross Competition Figure 41:7MM- Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Figure 42:7MM- Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 43:7MM- Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 44: United States-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Figure 45: United States-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 46: United States-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 47: Germany-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Figure 48: Germany-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 49: Germany-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 50: France-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Figure 51: France-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 52: France-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 53: Italy-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Figure 54: Italy-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 55: Italy-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 56: Spain-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Figure 57: Spain-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 58: Spain-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 59:UK-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Figure 60:UK-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 61:UK-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 62: Japan-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028) Figure 63: Japan-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028) Figure 64: Japan-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)